Evaluating Anti-ESKAPE Potential of Valeriana Officinalis L. Extract against Healthcare-Associated Infections in Tertiary Hospitals of Al-Kharj Governorate: An In Vitro Study
Mohammed S. Khan, MD Nadeem Bari · 2024
Read Evaluating Anti-ESKAPE Potential of Valeriana Officinalis L. Extract against Healthcare-Associated Infections in Tertiary Hospitals of Al-Kharj Governorate: An In Vitro Study by Mohammed S. Khan, MD Nadeem Bari (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11888659.txt.
Description
Mohammed Khan and Nadeem Bari test a valerian plant extract against the ESKAPE gang, the drug-resistant germs that haunt hospitals, in a 2024 study. The work ran in dishes, not patients, at hospitals in Saudi Arabia's Al-Kharj region. A methanol extract of valerian stems was profiled for its chemistry, then faced each of the six ESKAPE germs in well-diffusion tests.
The extract held all six back. The dose needed to stop growth ran lowest against Escherichia coli, mid-range for three others, and highest for the remaining two. The killing dose told a like story, with Escherichia coli again the softest target. A cell-safety assay rounded out the checks. The authors read the pattern as potent action at fairly low doses for a crude plant extract. They frame valerian as a candidate source for new hospital germ fighters, pending deeper work.
Catalog record
| CREATOR | Mohammed S. Khan, MD Nadeem Bari |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 14 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |